Studies of human NK cells and their role in tumor suppression have largely been restricted to in vitro experiments which lack the complexity of whole organisms, or mouse models which differ significantly from humans. In this study we showed that, in contrast to C57BL/6 Rag2(-/-)/gamma(c) (-/-) and NOD/Scid mice, newborn BALB/c Rag2(-/-)/gamma(c) (-/-) mice can support the development of human NK cells and CD56+ T cells after intrahepatic injection with hematopoietic stem cells. The human CD56(+) cells in BALB/c Rag2(-/-)/gamma(c) (-/-) mice were able to produce IFN-gamma in response to human IL-15 and polyI:C. NK cells from reconstituted Rag2(-/-)/gamma(c) (-/-) mice were also able to kill and inhibit the growth of K562 cells in vitro and were able to produce IFN-gamma in response to stimulation with K562 cells. In vivo, reconstituted Rag2(-/-)/gamma(c) (-/-) mice had higher survival rates after K562 challenge compared to non-reconstituted Rag2(-/-)/gamma(c) (-/-) mice and were able to control tumor burden in various organs. Reconstituted Rag2(-/-)/gamma(c) (-/-) mice represent a model in which functional human NK and CD56+ T cells can develop from stem cells and can thus be used to study human disease in a more clinically relevant environment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793015 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008379 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Targeting the Progression of Lupus-Like Disease in Humanized Mouse Model by Specific Dietary Components.
Mol Nutr Food Res
January 2025
Laboratory of Experimental Immunology, Department of Immunology, The "Stephan Аngeloff" Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, 1113, Bulgaria.
Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a number of immunological aberrations in the mechanisms of innate and adaptive immune responses. Spontaneous and induced mouse models of the disease have contributed significantly to the advancement in lupus treatments. The involvement of humanized models, engrafted with lupus patients' immune cells, represented the possibility to study the development of SLE.
View Article and Find Full Text PDFGroup 1 innate lymphoid cells protect liver transplants from ischemia-reperfusion injury via an interferon gamma-mediated pathway.
Am J Transplant
December 2024
The Dumont-UCLA Transplantation Center, Department of Surgery, Division of Liver and Pancreas Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, California, USA; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA. Electronic address:
As important immune regulatory cells, whether innate lymphoid cells (ILCs) are involved in liver transplantation (LT) remains unclear. In a murine orthotopic LT model, we dissected roles of ILCs in liver ischemia-reperfusion injury (IRI). Wild-type (WT) grafts suffered significantly higher IRI in Rag2-γc double knockout (DKO) than Rag2 knockout (KO) recipients, in association with downregulation of group 1 ILCs genes, including interferon gamma.
View Article and Find Full Text PDFEarly graft-infiltrating lymphocytes are not associated with graft rejection in a mouse model of skin transplantation.
Scand J Immunol
October 2024
Department of Gastroenterological Surgery 1, Hokkaido University, Sapporo, Japan.
Article Synopsis
- * In a study involving mouse skin transplants, GILs present at day 5 or day 7 post-transplant led to complete rejection of grafts, while GILs from day 3 did not induce rejection.
- * The findings suggest that GILs' ability to promote or prevent rejection is time-dependent, indicating that day 3 GILs had no effect on promoting graft rejection in skin transplant scenarios.
Current status of immunodeficient mouse models as substitutes to reduce cat and dog use in heartworm preclinical research.
F1000Res
September 2024
Department of Tropical Disease Biology, Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, Merseyside, UK.
Article Synopsis
- The veterinary heartworm prevention market is worth billions and is increasingly focusing on alternative drug testing due to drug resistance in dogs and cats.
- New research shows that specific genetically modified mice (like SCID and RAG2 γc) can be used for heartworm drug screening, reducing reliance on companion animals for testing.
- The study compares different mouse strains and treatments, revealing promising results with oxfendazole and suggesting that these mice models could aid both academia and industry in developing more effective heartworm treatments.
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
Front Immunol
September 2023
Department of Lymphoma/Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
Background: Lupus nephritis (LN) constitutes the most severe organ manifestations of systemic lupus erythematosus (SLE), where pathogenic T cells have been identified to play an essential role in 'helping' B cells to make autoantibodies and produce inflammatory cytokines that drive kidney injury in SLE. Regulatory T cells (Tregs), responsible for decreasing inflammation, are defective and decreased in SLE and have been associated with disease progression. We hypothesize that treatment with allogeneic, healthy Tregs derived from umbilical cord blood (UCB) may arrest such an inflammatory process and protect against kidney damage.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!